Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235337 · ClinicalTrials.gov registry record · NA
The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT02235337 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 248 participants.
The verdict
NCT02235337, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.
Interventions
- DRUG Riboflavin 400mg daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235337
The ClinicalTrials.gov registry entry for NCT02235337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Riboflavin 400mg daily is the first listed.
NCT02235337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02235337 about?
NCT02235337 is a clinical study titled "The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion". The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.
What is the current status of trial NCT02235337?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2014-09. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02235337?
The interventions under investigation include: Riboflavin 400mg daily (DRUG).
Who is sponsoring clinical trial NCT02235337?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.